$MPW
MEDICAL PROPERTIES TRUST INC Stock $mpw

$mpw Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000095017023020652 Filed on May 10, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$337.4M	$350.2M	$409.8M
YoY Change	-15.7%	-14.54%	12.97%
Cost Of Revenue	$24.68M	$182.1M	$93.99M
YoY Change	16.75%	93.69%	123.58%
Gross Profit	$312.7M	$168.2M	$315.8M
YoY Change	-17.51%	-46.75%	-1.53%
Gross Profit Margin	92.69%	48.01%	77.06%
Selling, General & Admin	$35.60M	$41.72M	$41.42M
YoY Change	-8.37%	0.72%	14.75%
% of Gross Profit	11.39%	24.81%	13.12%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$364.4M	$87.59M	$88.76M
YoY Change	317.33%	-1.32%	12.92%
% of Gross Profit	116.53%	52.09%	28.11%
Operating Expenses	$400.0M	$125.6M	$126.7M
YoY Change	224.7%	-0.91%	13.46%
Operating Profit	-$87.29M	$42.57M	$189.1M
YoY Change	-134.11%	-77.49%	-9.55%
Interest Expense	-$93.06M	$97.65M	$91.18M
YoY Change	26.5%	7.1%	4.84%
% of Operating Profit		229.41%	48.23%
Other Income/Expense, Net	-$10.51M	-$83.29M	$460.0M
YoY Change	-617.58%	-118.1%	3278.97%
Pretax Income	-$190.7M	$36.57M	$643.3M
YoY Change	-195.01%	-94.32%	273.51%
Income Tax	-$148.3M	$3.543M	$11.38M
% Of Pretax Income		9.69%	1.77%
Net Earnings	-$42.51M	$32.79M	$631.7M
YoY Change	-122.42%	-94.81%	285.68%
Net Earnings / Revenue	-12.6%	9.36%	154.14%
Basic Earnings Per Share	-$0.07	$0.05	$1.05
Diluted Earnings Per Share	-$0.07	$0.05	$1.055M
COMMON SHARES
Basic Shares Outstanding	598.3M	598.3M	598.7M
Diluted Shares Outstanding	598.3M	598.3M	598.9M

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$324.1M	$302.3M	$248.8M
YoY Change	25.96%	21.49%	-66.69%
Cash & Equivalents	$324.1M	$302.3M	$248.8M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$1.104B	$1.113B	$909.3M
YoY Change	14.97%	22.43%	-29.62%
LONG-TERM ASSETS
Property, Plant & Equipment	$17.11B	$17.51B	$18.25B
YoY Change	-4.28%	-4.06%	25.45%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$18.10B	$18.54B	$18.91B
YoY Change	-3.63%	-1.97%	8.33%
TOTAL ASSETS
Total Short-Term Assets	$1.104B	$1.113B	$909.3M
Total Long-Term Assets	$18.10B	$18.54B	$18.91B
Total Assets	$19.20B	$19.65B	$19.82B
YoY Change	-2.73%	-0.85%	5.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$444.9M	$595.3M	$595.0M
YoY Change	-20.87%	0.04%	33.41%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$602.3M	$739.4M	$761.7M
YoY Change	-16.02%	-2.93%	25.89%
LONG-TERM LIABILITIES
Long-Term Debt	$10.24B	$10.44B	$10.12B
YoY Change	0.97%	3.16%	1.18%
Other Long-Term Liabilities	$49.77M	$29.39M	$18.83M
YoY Change	134.63%	56.05%	-14.39%
Total Long-Term Liabilities	$10.29B	$10.47B	$10.14B
YoY Change	1.25%	3.26%	1.15%
TOTAL LIABILITIES
Total Short-Term Liabilities	$602.3M	$739.4M	$761.7M
Total Long-Term Liabilities	$10.29B	$10.47B	$10.14B
Total Liabilities	$10.89B	$11.21B	$10.90B
YoY Change	0.07%	2.83%	2.52%
SHAREHOLDERS EQUITY
Retained Earnings	-$241.3M	-$25.41M	$370.0M
YoY Change	-162.59%	-106.87%
Common Stock	$8.548B	$8.542B	$8.548B
YoY Change	-0.11%	-0.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.314B	$8.442B	$8.913B
YoY Change
Total Liabilities & Shareholders Equity	$19.20B	$19.65B	$19.82B
YoY Change	-2.73%	-0.85%	5.72%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$42.51M	$32.79M	$631.7M
YoY Change	-122.42%	-94.81%	285.68%
Depreciation, Depletion And Amortization	$364.4M	$87.59M	$88.76M
YoY Change	317.33%	-1.32%	12.92%
Cash From Operating Activities	$76.53M	$135.6M	$179.4M
YoY Change	-53.51%	-24.38%	-4.95%
INVESTING ACTIVITIES
Capital Expenditures	$177.6M	$86.19M	-$760.9M
YoY Change	-164.24%	-111.33%	-57.21%
Acquisitions
YoY Change
Other Investing Activities	$569.5M	$103.4M	$1.640B
YoY Change	-932.46%	-93.7%	-53001.42%
Cash From Investing Activities	$391.8M	$17.18M	$879.0M
YoY Change	-213.6%	-98.05%	-149.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net			$869.6M
YoY Change			26.13%
Cash From Financing Activities	-461.8M	-89.13M	-1.264B
YoY Change	-329.65%	-92.95%	-170.79%
NET CHANGE
Cash From Operating Activities	76.53M	135.6M	179.4M
Cash From Investing Activities	391.8M	17.18M	879.0M
Cash From Financing Activities	-461.8M	-89.13M	-1.264B
Net Change In Cash	6.534M	63.70M	-205.4M
YoY Change	-68.61%	-131.01%	-206.78%
FREE CASH FLOW
Cash From Operating Activities	$76.53M	$135.6M	$179.4M
Capital Expenditures	$177.6M	$86.19M	-$760.9M
Free Cash Flow	-$101.1M	$49.46M	$940.3M
YoY Change	-122.92%	-94.74%	-52.2%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	598300000
CY2023Q1	mpw	Land Buildings And Improvements Intangible Lease Assets And Other LandBuildingsAndImprovementsIntangibleLeaseAssetsAndOther	13092510000
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001287865
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents Asset Statement Of Financial Position Extensible List RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssets
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents Asset Statement Of Financial Position Extensible List RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssets
CY2023Q1	us-gaap	Derivative Instrument Gain Loss Reclassified From Aoci Into Income Effective Portion Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents Asset Statement Of Financial Position Extensible List RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssets
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents Asset Statement Of Financial Position Extensible List RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssets
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-32559
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	MEDICAL PROPERTIES TRUST, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-0191742
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1000 URBAN CENTER DRIVE
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	SUITE 501
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	BIRMINGHAM
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	AL
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	35242
CY2022Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	1711608000
CY2023Q1	dei	City Area Code CityAreaCode	205
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	969-3755
CY2023Q1	dei	Security12b Title Security12bTitle	Common stock, par value $0.001 per share, of Medical Properties Trust, Inc.
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	308166000
CY2023Q1	dei	Trading Symbol TradingSymbol	MPW
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022Q4	mpw	Land Buildings And Improvements Intangible Lease Assets And Other LandBuildingsAndImprovementsIntangibleLeaseAssetsAndOther	13862415000
CY2023Q1	us-gaap	Net Investment In Lease NetInvestmentInLease	1582416000
CY2022Q4	us-gaap	Net Investment In Lease NetInvestmentInLease	1691323000
CY2023Q1	us-gaap	Real Estate Heldforsale RealEstateHeldforsale	881587000
CY2023Q1	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	346446000
CY2022Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	364101000
CY2023Q1	mpw	Gross Investment In Real Estate Assets GrossInvestmentInRealEstateAssets	15902959000
CY2022Q4	mpw	Gross Investment In Real Estate Assets GrossInvestmentInRealEstateAssets	15917839000
CY2023Q1	mpw	Real Estate Accumulated Depreciation And Amortization RealEstateAccumulatedDepreciationAndAmortization	1207699000
CY2022Q4	mpw	Real Estate Accumulated Depreciation And Amortization RealEstateAccumulatedDepreciationAndAmortization	1193312000
CY2023Q1	mpw	Net Investment In Real Estate Assets NetInvestmentInRealEstateAssets	14695260000
CY2022Q4	mpw	Net Investment In Real Estate Assets NetInvestmentInRealEstateAssets	14724527000
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	302321000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	235668000
CY2023Q1	mpw	Interest And Rent Receivable InterestAndRentReceivable	169511000
CY2022Q4	mpw	Interest And Rent Receivable InterestAndRentReceivable	167035000
CY2023Q1	mpw	Straight Line Rent Receivable StraightLineRentReceivable	810911000
CY2022Q4	mpw	Straight Line Rent Receivable StraightLineRentReceivable	787166000
CY2023Q1	us-gaap	Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures	1506474000
CY2022Q4	us-gaap	Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures	1497903000
CY2023Q1	mpw	Investments In Unconsolidated Operating Entities InvestmentsInUnconsolidatedOperatingEntities	1310460000
CY2022Q4	mpw	Investments In Unconsolidated Operating Entities InvestmentsInUnconsolidatedOperatingEntities	1444872000
CY2023Q1	mpw	Acquisition Loans And Other Loans AcquisitionLoansAndOtherLoans	276367000
CY2022Q4	mpw	Acquisition Loans And Other Loans AcquisitionLoansAndOtherLoans	227839000
CY2023Q1	us-gaap	Other Assets OtherAssets	578853000
CY2022Q4	us-gaap	Other Assets OtherAssets	572990000
CY2023Q1	us-gaap	Assets Assets	19650157000
CY2022Q4	us-gaap	Assets Assets	19658000000
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	10438151000
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	10268412000
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	595269000
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	621324000
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	29391000
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	27727000
CY2023Q1	mpw	Obligations To Tenants And Other Lease Liabilities ObligationsToTenantsAndOtherLeaseLiabilities	144092000
CY2022Q4	mpw	Obligations To Tenants And Other Lease Liabilities ObligationsToTenantsAndOtherLeaseLiabilities	146130000
CY2023Q1	us-gaap	Liabilities Liabilities	11206903000
CY2022Q4	us-gaap	Liabilities Liabilities	11063593000
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	598302000
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	598302000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	597476000
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	597476000
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	598000
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	597000
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	8541414000
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	8535140000
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25413000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	116285000
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-74919000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-59184000
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	8441680000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	8592838000
CY2023Q1	us-gaap	Minority Interest MinorityInterest	1574000
CY2022Q4	us-gaap	Minority Interest MinorityInterest	1569000
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8443254000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8594407000
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19650157000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19658000000
CY2023Q1	mpw	Rent Billed RentBilled	248157000
CY2022Q1	mpw	Rent Billed RentBilled	263402000
CY2023Q1	mpw	Straight Line Rent Revenue Net Of Write Offs StraightLineRentRevenueNetOfWriteOffs	56693000
CY2022Q1	mpw	Straight Line Rent Revenue Net Of Write Offs StraightLineRentRevenueNetOfWriteOffs	61044000
CY2023Q1	us-gaap	Direct Financing Lease Revenue DirectFinancingLeaseRevenue	13195000
CY2022Q1	us-gaap	Direct Financing Lease Revenue DirectFinancingLeaseRevenue	51776000
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	32166000
CY2022Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	33578000
CY2023Q1	us-gaap	Revenues Revenues	350211000
CY2022Q1	us-gaap	Revenues Revenues	409800000
CY2023Q1	us-gaap	Interest Expense InterestExpense	97654000
CY2022Q1	us-gaap	Interest Expense InterestExpense	91183000
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	83860000
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	85316000
CY2023Q1	mpw	Costs Of Leased And Rented Property Or Equipment CostsOfLeasedAndRentedPropertyOrEquipment	7110000
CY2022Q1	mpw	Costs Of Leased And Rented Property Or Equipment CostsOfLeasedAndRentedPropertyOrEquipment	8598000
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	41724000
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	41424000
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	230348000
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	226521000
CY2023Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	62000
CY2022Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	451638000
CY2023Q1	mpw	Real Estate And Other Impairment Charges RealEstateAndOtherImpairmentCharges	89538000
CY2022Q1	mpw	Real Estate And Other Impairment Charges RealEstateAndOtherImpairmentCharges	4875000
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	11352000
CY2023Q1	mpw	Stock Issued During Period Value Stock Vesting Satisfaction Of Tax Withholding StockIssuedDuringPeriodValueStockVestingSatisfactionOfTaxWithholding	-5554000
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	7338000
CY2022Q1	mpw	Debt Refinancing And Unutilized Financing Costs DebtRefinancingAndUnutilizedFinancingCosts	8816000
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5166000
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	14762000
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-83290000
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	460047000
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	36573000
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	643326000
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3543000
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11379000
CY2023Q1	us-gaap	Profit Loss ProfitLoss	33030000
CY2022Q1	us-gaap	Profit Loss ProfitLoss	631947000
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	236000
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	266000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	32794000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	631681000
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.05
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.05
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	598302000
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	598676000
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	598310000
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	598932000
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.29
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.29
CY2023Q1	us-gaap	Profit Loss ProfitLoss	33030000
CY2022Q1	us-gaap	Profit Loss ProfitLoss	631947000
CY2023Q1	mpw	Other Comprehensive Income Unrealized Gain Loss On Derivatives Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesNetOfTax	-15325000
CY2022Q1	mpw	Other Comprehensive Income Unrealized Gain Loss On Derivatives Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesNetOfTax	44932000
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	28143000
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-13215000
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	28553000
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	17295000
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	663664000
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	236000
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	266000
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	17059000
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	663398000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8594407000
CY2023Q1	us-gaap	Profit Loss ProfitLoss	33030000
CY2023Q1	mpw	Other Comprehensive Income Unrealized Gain Loss On Derivatives Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesNetOfTax	-15325000
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	28143000
CY2023Q1	mpw	Reclassification Of Interest Rate Swap Gain To Earnings Net Of Tax ReclassificationOfInterestRateSwapGainToEarningsNetOfTax	-28553000
CY2023Q1	mpw	Stock Issued During Period Value Stock Vesting And Amortization Of Stock Based Compensation StockIssuedDuringPeriodValueStockVestingAndAmortizationOfStockBasedCompensation	11829000
CY2023Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	231000
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.29
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	174492000
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8443254000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8445671000
CY2022Q1	us-gaap	Profit Loss ProfitLoss	631947000
CY2022Q1	mpw	Other Comprehensive Income Unrealized Gain Loss On Derivatives Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesNetOfTax	44932000
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-13215000
CY2022Q1	mpw	Stock Issued During Period Value Stock Vesting And Amortization Of Stock Based Compensation StockIssuedDuringPeriodValueStockVestingAndAmortizationOfStockBasedCompensation	11804000
CY2022Q1	mpw	Stock Issued During Period Value Stock Vesting Satisfaction Of Tax Withholding StockIssuedDuringPeriodValueStockVestingSatisfactionOfTaxWithholding	27919000
CY2022Q1	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	929000
CY2022Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	772000
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.29
CY2022Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	174018000
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8919359000
CY2023Q1	us-gaap	Profit Loss ProfitLoss	33030000
CY2022Q1	us-gaap	Profit Loss ProfitLoss	631947000
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	87586000
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	88760000
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	4014000
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	5285000
CY2023Q1	mpw	Straight Line Rent Revenue And Other StraightLineRentRevenueAndOther	58566000
CY2022Q1	mpw	Straight Line Rent Revenue And Other StraightLineRentRevenueAndOther	75385000
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	11829000
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	11804000
CY2023Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	62000
CY2022Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	451638000
CY2023Q1	mpw	Real Estate And Other Impairment Charges RealEstateAndOtherImpairmentCharges	89538000
CY2022Q1	mpw	Real Estate And Other Impairment Charges RealEstateAndOtherImpairmentCharges	4875000
CY2023Q1	mpw	Straight Line Rent And Other Recovery Write Off StraightLineRentAndOtherRecoveryWriteOff	2192000
CY2022Q1	mpw	Straight Line Rent And Other Recovery Write Off StraightLineRentAndOtherRecoveryWriteOff	-2271000
CY2022Q1	mpw	Debt Refinancing And Unutilized Financing Costs DebtRefinancingAndUnutilizedFinancingCosts	8816000
CY2023Q1	mpw	Tax Rate Changes TaxRateChanges	-7305000
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	8505000
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1040000
CY2023Q1	mpw	Increase Decrease In Interest And Rent Receivable IncreaseDecreaseInInterestAndRentReceivable	514000
CY2022Q1	mpw	Increase Decrease In Interest And Rent Receivable IncreaseDecreaseInInterestAndRentReceivable	12431000
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2493000
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	41000
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-15696000
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-21648000
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	600000
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-7646000
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	135648000
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	179387000
CY2023Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	72900000
CY2022Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	724795000
CY2023Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	100000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	251766000
CY2023Q1	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	221876000
CY2022Q1	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	6355000
CY2023Q1	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	50000000
CY2022Q1	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	10414000
CY2023Q1	mpw	Construction In Progress Equipment And Other ConstructionInProgressEquipmentAndOther	13292000
CY2022Q1	mpw	Construction In Progress Equipment And Other ConstructionInProgressEquipmentAndOther	36115000
CY2023Q1	mpw	Payments For Capital Additions And Other Investments Net PaymentsForCapitalAdditionsAndOtherInvestmentsNet	68606000
CY2022Q1	mpw	Payments For Capital Additions And Other Investments Net PaymentsForCapitalAdditionsAndOtherInvestmentsNet	67605000
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	17178000
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	879034000
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	869606000
CY2023Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	95919000
CY2022Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-198599000
CY2023Q1	us-gaap	Payments Of Ordinary Dividends PaymentsOfOrdinaryDividends	176580000
CY2022Q1	us-gaap	Payments Of Ordinary Dividends PaymentsOfOrdinaryDividends	176494000
CY2023Q1	mpw	Payments For Proceeds From Lease Deposits And Other Obligations To Tenants PaymentsForProceedsFromLeaseDepositsAndOtherObligationsToTenants	2691000
CY2022Q1	mpw	Payments For Proceeds From Lease Deposits And Other Obligations To Tenants PaymentsForProceedsFromLeaseDepositsAndOtherObligationsToTenants	-15168000
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	5554000
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	27919000
CY2023Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-219000
CY2022Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-6366000
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-89125000
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1263816000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	63701000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-205395000
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2927000
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-4721000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	241538000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	461882000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	308166000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	251766000
CY2023Q1	us-gaap	Interest Paid InterestPaid	116436000
CY2022Q1	us-gaap	Interest Paid InterestPaid	111012000
CY2023Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	174492000
CY2022Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	174018000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	235668000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	459227000
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	5870000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2655000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	241538000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	461882000
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	302321000
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	248846000
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	5845000
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2920000
CY2023Q1	mpw	Percentage Of Leased Assets Owned PercentageOfLeasedAssetsOwned	1
CY2023Q1	mpw	Number Of Facilities NumberOfFacilities	444
CY2023Q1	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	31
CY2022Q1	us-gaap	Gain Loss On Disposition Of Real Estate Discontinued Operations GainLossOnDispositionOfRealEstateDiscontinuedOperations	15000000
CY2022Q1	us-gaap	Proceeds From Sale Of Real Estate ProceedsFromSaleOfRealEstate	48000000
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Reclassifications</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Certain amounts in the condensed consolidated financial statements for prior periods have been reclassified to conform to the current period presentation.</span></p>
CY2023Q1	mpw	Loans And Or Equity Investments In Variable Interest Entities LoansAndOrEquityInvestmentsInVariableInterestEntities	425000000
CY2022Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	25727000
CY2023Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	72900000
CY2022Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	724795000
CY2023Q1	mpw	Business Combination Loans Paid Down On Acquisition Loans BusinessCombinationLoansPaidDownOnAcquisitionLoans	22900000
CY2023Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	50000000
CY2022Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	724795000
CY2022Q1	mpw	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities And Other Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesAndOtherLiabilities	26000000
CY2023Q1	mpw	Development Projects Original Commitment Amount DevelopmentProjectsOriginalCommitmentAmount	405320000
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	182060000
CY2023Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	79000000
CY2023Q1	mpw	Straight Line Rent Receivables StraightLineRentReceivables	37400000
CY2023Q1	mpw	Estimated Fees To Sell The Hospitals EstimatedFeesToSellTheHospitals	8000000
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	13000000
CY2023Q1	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	29000000
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	10492425000
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	10325499000
CY2023Q1	us-gaap	Lessor Operating Lease Renewal Term LessorOperatingLeaseRenewalTerm	P5Y
CY2023Q1	mpw	Leases Annual Rent Escalations Percentage LeasesAnnualRentEscalationsPercentage	0.99
CY2023Q1	us-gaap	Direct Financing Lease Lease Receivable DirectFinancingLeaseLeaseReceivable	626721000
CY2022Q4	us-gaap	Direct Financing Lease Lease Receivable DirectFinancingLeaseLeaseReceivable	880253000
CY2023Q1	us-gaap	Direct Financing Lease Unguaranteed Residual Asset DirectFinancingLeaseUnguaranteedResidualAsset	203818000
CY2022Q4	us-gaap	Direct Financing Lease Unguaranteed Residual Asset DirectFinancingLeaseUnguaranteedResidualAsset	203818000
CY2023Q1	mpw	Direct Financing Lease Unearned Income And Allowance For Credit Loss DirectFinancingLeaseUnearnedIncomeAndAllowanceForCreditLoss	588097000
CY2022Q4	mpw	Direct Financing Lease Unearned Income And Allowance For Credit Loss DirectFinancingLeaseUnearnedIncomeAndAllowanceForCreditLoss	731915000
CY2023Q1	us-gaap	Direct Financing Lease Net Investment In Lease DirectFinancingLeaseNetInvestmentInLease	242442000
CY2022Q4	us-gaap	Direct Financing Lease Net Investment In Lease DirectFinancingLeaseNetInvestmentInLease	352156000
CY2023Q1	mpw	Other Financing Leases Net Of Allowance For Credit Loss OtherFinancingLeasesNetOfAllowanceForCreditLoss	1339974000
CY2022Q4	mpw	Other Financing Leases Net Of Allowance For Credit Loss OtherFinancingLeasesNetOfAllowanceForCreditLoss	1339167000
CY2023Q1	us-gaap	Net Investment In Lease NetInvestmentInLease	1582416000
CY2022Q4	us-gaap	Net Investment In Lease NetInvestmentInLease	1691323000
CY2023Q1	mpw	Percentage Of Properties Occupied By Tenants PercentageOfPropertiesOccupiedByTenants	0.99
CY2023Q1	mpw	Number Of Properties Vacant NumberOfPropertiesVacant	5
CY2023Q1	mpw	Remaining Outstanding Deferred Rent To Be Received RemainingOutstandingDeferredRentToBeReceived	12200000
CY2023Q1	us-gaap	Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures	1506474000
CY2022Q4	us-gaap	Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures	1497903000
CY2023Q1	mpw	Investments In Unconsolidated Operating Entities InvestmentsInUnconsolidatedOperatingEntities	1310460000
CY2022Q4	mpw	Investments In Unconsolidated Operating Entities InvestmentsInUnconsolidatedOperatingEntities	1444872000
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	121146000
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	48527000
CY2023Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	986000
CY2022Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	5412000
CY2023Q1	mpw	Financing Receivable Allowances Of Credit Losses Related To Financial Instruments Sold FinancingReceivableAllowancesOfCreditLossesRelatedToFinancialInstrumentsSold	-160000
CY2022Q1	mpw	Financing Receivable Allowances Of Credit Losses Related To Financial Instruments Sold FinancingReceivableAllowancesOfCreditLossesRelatedToFinancialInstrumentsSold	-6000
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	121972000
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	53933000
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	54274000
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	57087000
CY2023Q1	mpw	Interest And Rent Receivable InterestAndRentReceivable	169511000
CY2023Q1	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	160947000
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	10438151000
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	10268412000
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	493480000
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	931553000
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	1405540000
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	2689837000
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	1600000000
CY2023Q1	mpw	Long Term Debt Maturities Repayments Of Principal After Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour	3372015000
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	10492425000
CY2023Q1	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2022-03-15
CY2022Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	1000000000
CY2023Q1	us-gaap	Line Of Credit Facility Initiation Date1 LineOfCreditFacilityInitiationDate1	2021-07-27
CY2023Q1	mpw	Percentage Of Dividends Payable On Basis Of Adjusted Operating Funds PercentageOfDividendsPayableOnBasisOfAdjustedOperatingFunds	0.95
CY2023Q1	mpw	Percentage Of Dividends Payable On Senior Unsecured Notes PercentageOfDividendsPayableOnSeniorUnsecuredNotes	0.95
CY2023Q1	mpw	Maximum Percentage Of Unencumbered Assets MaximumPercentageOfUnencumberedAssets	1.50
CY2023Q1	mpw	Income Tax Benefit Related To The Initial Loan Impairment IncomeTaxBenefitRelatedToTheInitialLoanImpairment	5000000
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	11800000
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	11800000
CY2022Q4	mpw	Interest And Rent Receivable InterestAndRentReceivable	167035000
CY2022Q4	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	163101000
CY2023Q1	mpw	Loans Loans	1511182000
CY2023Q1	us-gaap	Loans Held For Sale Fair Value Disclosure LoansHeldForSaleFairValueDisclosure	1456753000
CY2022Q4	mpw	Loans Loans	1405615000
CY2022Q4	us-gaap	Loans Held For Sale Fair Value Disclosure LoansHeldForSaleFairValueDisclosure	1360113000
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	10438151000
CY2023Q1	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	8594584000
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	10268412000
CY2022Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	8697042000
CY2023Q1	us-gaap	Profit Loss ProfitLoss	33030000
CY2022Q1	us-gaap	Profit Loss ProfitLoss	631947000
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	236000
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	266000
CY2023Q1	mpw	Undistributed Earning Allocated To Participating Securities UndistributedEarningAllocatedToParticipatingSecurities	515000
CY2022Q1	mpw	Undistributed Earning Allocated To Participating Securities UndistributedEarningAllocatedToParticipatingSecurities	402000
CY2023Q1	mpw	Net Income Less Participating Securities Share In Earnings NetIncomeLessParticipatingSecuritiesShareInEarnings	32279000
CY2022Q1	mpw	Net Income Less Participating Securities Share In Earnings NetIncomeLessParticipatingSecuritiesShareInEarnings	631279000
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	598302000
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	598676000
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	8000
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	256000
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	598310000
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	598932000

Files In Submission

Name	View Source	Status
mpw-20230331_pre.xml	Edgar Link	unprocessable
0000950170-23-020652-index-headers.html	Edgar Link	pending
0000950170-23-020652-index.html	Edgar Link	pending
0000950170-23-020652.txt	Edgar Link	pending
0000950170-23-020652-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mpw-20230331.htm	Edgar Link	pending
mpw-20230331.xsd	Edgar Link	pending
mpw-ex31_1.htm	Edgar Link	pending
mpw-ex31_2.htm	Edgar Link	pending
mpw-ex31_3.htm	Edgar Link	pending
mpw-ex31_4.htm	Edgar Link	pending
mpw-ex32_1.htm	Edgar Link	pending
mpw-ex32_2.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
mpw-20230331_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
mpw-20230331_def.xml	Edgar Link	unprocessable
mpw-20230331_lab.xml	Edgar Link	unprocessable
mpw-20230331_htm.xml	Edgar Link	completed
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MPW
MEDICAL PROPERTIES TRUST INC Stock $mpw

2023 Q2 Form 10-Q Financial Statement

#000095017023020652 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MPW MEDICAL PROPERTIES TRUST INC Stock $mpw

2023 Q2 Form 10-Q Financial Statement

#000095017023020652 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MPW
MEDICAL PROPERTIES TRUST INC Stock $mpw